The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice
Abstract
Elevated colonic luminal serine-protease (Ser-P) activity of diarrhea-predominant IBS (IBS-D) patients evokes a proteinase-activated receptor (PAR)-2-mediated colonic hypersensitivity in mice. Despite similarly elevated Ser-P levels in feces, patients with IBD exhibit visceral hypo- or normosensitivity to rectal distension, as opposed to IBS-D. To explain these discrepancies we studied the effect of colonic infusion of fecal supernatants from ulcerative colitis (UC) patients to colorectal mechanical sensitivity of mice and explored the involvement of PAR-4 and its activator Cathepsin-G (Cat-G). Fecal protease activities were assayed in healthy subjects, IBS-D and UC patients in presence or not of antiproteases or Cat-G inhibitor. Following intracolonic infusion of fecal supernatants from healthy subjects, IBS-D and UC patients or PAR-4 activating peptide (PAR-4-AP) or Cat-G, EMG response to colorectal balloon distension was recorded in mice. This nociceptive response was also determined after treatment with pepducin (PAR-4 antagonist) on UC supernatant or after a preincubation with antiproteases or Cat-G inhibitor. In contrast to IBS-D supernatant, UC supernatant promoted colonic hyposensitivity to distension, an effect mimicked by PAR-4-AP or Cat-G. UC supernatant-induced hypoalgesia was inhibited by a cocktail of antiproteases. However, blockade of PAR-4 or Cat-G inhibition resulted in colonic hypersensitivity similar to that observed after IBS-D supernatant infusion. Despite similarly elevated Ser-P activities, IBS-D and UC fecal supernatant display visceral pro- and antinociceptive effects in mice, respectively. Visceral hyposensitivity induced by fecal supernatant from UC patients results from PAR-4 activation by cathepsin-G, counterbalancing the pronociceptive effect of simultaneous PAR-2 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intracolonic administration of fecal supernatants from IBS-D and IBS-C patients increased the visceromotor response to distension, with evidence of both allodynia and hyperalgesia.159,160”
From The emerging roles of bacterial proteases in intestinal diseases (2023) · cites this paper as [159]
In the citing paper
“In contrast, fecal supernatants from UC patients had the opposite effect, decreasing the visceromotor response in a PAR-4-dependent manner.159”
From The emerging roles of bacterial proteases in intestinal diseases (2023) · cites this paper as [159]
Citations
Cites
1 retracted
Uehara, A., Muramoto, K., Takada, H., & Sugawara, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5690 · Cited by 157
RetractedBarbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Rachmilewitz, D. (1989) · BMJ · doi:10.1136/bmj.298.6666.82 · Cited by 1,038
Neutrophil serine proteases: specific regulators of inflammation
Pham, C. T. N. (2006) · Nature reviews. Immunology · doi:10.1038/nri1841 · Cited by 1,017
Altered rectal perception is a biological marker of patients with irritable bowel syndrome
Mertz, H., Naliboff, B. D., Munakata, J., Niazi, N., & Mayer, E. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90267-8 · Cited by 976
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome
Ritchie, J. (1973) · Gut · doi:10.1136/gut.14.2.125 · Cited by 832
Cloning and characterization of human protease-activated receptor 4
Xu, W., Andersen, H., Whitmore, T. E., Presnell, S., Yee, D. P., Ching, A. F. T., Gilbert, T., Davie, E. W., & Foster, D. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6642 · Cited by 815
The role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764
Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583
Cited by
Sorted by citations
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M. D., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 1,102
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Moloney, R. D., Johnson, A. C., O’Mahony, S. M., Dinan, T. G., Meerveld, B. G., & Cryan, J. F. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12490 · Cited by 412
Structure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Vivinus-Nébot, M., Frin-Mathy, G., Bzioueche, H., Dainese, R., Bernard, G., Anty, R., Filippi, J., Saint‐Paul, M., Tulić, M. K., Verhasselt, V., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304066 · Cited by 365
Zhao, N., Chen, J., Carroll, I. M., Ringel-Kulka, T., Epstein, M. P., Zhou, H., Zhou, J. J., Ringel, Y., Li, H., & Wu, M. C. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.003 · Cited by 306
Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L. G., Mäkivuokko, H., Kajander, K., & Palva, A. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-95 · Cited by 307
Layer, P., Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S., Claßen, M., Enck, P., Frieling, T., Haag, S., Holtmann, G., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0029-1245976 · Cited by 236
Protease inhibition as new therapeutic strategy for GI diseases
Vergnolle, N. (2016) · Gut · doi:10.1136/gutjnl-2015-309147 · Cited by 226
Veldhuis, N. A., Poole, D. P., Grace, M. S., McIntyre, P., & Bunnett, N. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009555 · Cited by 177
O’Callaghan, K., Kuliopulos, A., & Covic, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.355461 · Cited by 159
Mast cell–nerve axis with a focus on the human gut
Bühner, S., & Schemann, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.004 · Cited by 151
Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?
Hughes, P. A., Zola, H., Penttila, I., Blackshaw, L. A., Andrews, J. M., & Krumbiegel, D. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.120 · Cited by 147
Bacterial proteases in IBD and IBS
Steck, N., Mueller, K., Schemann, M., & Haller, D. (2011) · Gut · doi:10.1136/gutjnl-2011-300775 · Cited by 125
Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents
Clemente, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10305 · Cited by 113
Valdez-Morales, E. E., Overington, J., Guerrero-Alba, R., Ochoa-Cortes, F., Ibeakanma, C. O., Spreadbury, I., Bunnett, N. W., Beyak, M., & Vanner, S. J. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.241 · Cited by 107
Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
Edogawa, S., Edwinson, A. L., Peters, S. A., Chikkamenahalli, L. L., Sundt, W., Graves, S., Gurunathan, S. V., Breen-Lyles, M., Johnson, S., Dyer, R., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317416 · Cited by 101
The emerging roles of bacterial proteases in intestinal diseases
Caminero, A., Guzman, M., Libertucci, J., & Lomax, A. E. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2181922 · Cited by 92
Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2
Maharshak, N., Huh, E. Y., Paiboonrungruang, C., Shanahan, M., Thurlow, L., Herzog, J., Djukic, Z., Orlando, R., Pawlinski, R., Ellermann, M., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00425-15 · Cited by 86
Pharmacology, Biodistribution, and Efficacy of GPCR-Based Pepducins in Disease Models
Tressel, S. L., Κούκος, Γ., Tchernychev, B., Jacques, S. L., Covic, L., & Kuliopulos, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_19 · Cited by 81
Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications
Carroll, I. M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7531 · Cited by 82
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
Burgell, R., & Scott, S. (2012) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2012.18.4.373 · Cited by 172
Cytokines and irritable bowel syndrome: Where do we stand?
Bashashati, M., Rezaei, N., Andrews, C. N., Chen, C., Daryani, N. E., Sharkey, K. A., & Storr, M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.019 · Cited by 74
BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit
Wang, P., Du, C., Chen, F.-X., Li, C., Yu, Y.-B., Han, T., Akhtar, S., Zuo, X.-L., Tan, X., & Li, Y. (2016) · Scientific Reports · doi:10.1038/srep20320 · Cited by 72
Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota
Carroll, I. M., Ringel‐Kulka, T., Ferrier, L., Wu, M. C., Siddle, J. P., Bueno, L. P., & Ringel, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078017 · Cited by 70
Self-citationMultispecies probiotic protects gut barrier function in experimental models
Vivinus-Nébot, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6832 · Cited by 72
Luk, B., Horvath, T. D., Engevik, K. A., Ruan, W. H., Haidacher, S. J., Hoch, K. M., Oezguen, N., Spinler, J. K., Haag, A. M., Versalovic, J. A., et al. (2021) · Biomolecules · doi:10.3390/biom11081091 · Cited by 70
Clemente, A., Sonnante, G., & Domoney, C. (2011) · Current Protein & Peptide Science · doi:10.2174/138920311796391133 · Cited by 63
Ceuleers, H., Spaendonk, H. V., Hanning, N., Heirbaut, J., Lambeir, A., Joossens, J., Augustyns, K., Man, J. G. D., Meester, I. D., & Winter, B. Y. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10275 · Cited by 63
Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds
Basson, A. R., Ahmed, S. U. M., Almutairi, R., Seo, B., & Cominelli, F. (2021) · Foods · doi:10.3390/foods10040774 · Cited by 68
Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria
Sessenwein, J. L., Baker, C. C., Pradhananga, S., Maitland, M. E., Petrof, E. O., Allen-Vercoe, E., Noordhof, C., Reed, D. E., Vanner, S. J., & Lomax, A. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1672-17.2017 · Cited by 58
Impact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 54
Ceuleers, H., Hanning, N., Heirbaut, J., Van Remoortel, S., Joossens, J., Van Der Veken, P., Francque, S. M., De bruyn, M., Lambeir, A., De Man, J. G., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14396 · Cited by 49
Visceral pain from colon and rectum: the mechanotransduction and biomechanics
Feng, B., & Guo, T. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02088-8 · Cited by 54
Bühner, S., Hahne, H., Hartwig, K., Li, Q., Vignali, S., Ostertag, D., Meng, C., Hörmannsperger, G., Braak, B., Pehl, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193943 · Cited by 48
Existing and Emerging Therapies for Managing Constipation and Diarrhea
Bharucha, A., Wouters, M., & Tack, J. (2017) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2017.10.015 · Cited by 36
Activity of Protease-Activated Receptors in the Human Submucous Plexus
Mueller, K., Michel, K., Krueger, D., Demir, İ. E., Ceyhan, G. O., Zeller, F., Kreis, M. E., & Schemann, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.034 · Cited by 44
Mkaouar, H., Akermi, N., Mariaule, V., Boudebbouze, S., Gaci, N., Szukala, F., Pons, N., Marquez, J., Gargouri, A. F., Maguin, E., et al. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0596-2 · Cited by 43
Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix
Porras, A. M., Zhou, H., Shi, Q., Xiao, X., Bank, J. L. C., Longman, R., & Brito, I. (2022) · mBio · doi:10.1128/mbio.02201-22 · Cited by 39
The paradox of painless periodontal disease
Gaurilcikaite, E., Renton, T. F., & Grant, A. D. (2016) · Oral Diseases · doi:10.1111/odi.12537 · Cited by 40
Contribution of membrane receptor signalling to chronic visceral pain
Sadeghi, M., Erickson, A., Castro, J., Deiteren, A., Harrington, A. M., Grundy, L., Adams, D. J., & Brierley, S. M. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.02.017 · Cited by 40
Wang, P., Chen, F.-X., Du, C., Li, C., Yu, Y., Zuo, X., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep10121 · Cited by 41
Peripheral analgesia: Hitting pain where it hurts
McDougall, J. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.011 · Cited by 38
Bacterial modulation of visceral sensation: mediators and mechanisms
Lomax, A. E., Pradhananga, S., Sessenwein, J. L., & O’Malley, D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00052.2019 · Cited by 36
Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome
Han, W., Zhimin, W. A. N. G., Lu, X. F., & Guo, C. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01841.x · Cited by 32
Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain
Tuck, C. J., Omar, A. A., Palma, G. D., Osman, S., Jiménez-Vargas, N. N., Yu, Y., Bennet, S., López-López, C., Jaramillo-Polanco, J., Baker, C. C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327260 · Cited by 31
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Visceral hypersensitivity in female but not in male serotonin transporter knockout rats
Galligan, J. J., Patel, B. A., Schneider, S. P., Wang, H., Zhao, H., Novotný, M., Bian, X., Kabeer, R., Fried, D. E., & Swain, G. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12133 · Cited by 29
Zhang, H., Zeng, X., & He, S. (2014) · Mediators of Inflammation · doi:10.1155/2014/829068 · Cited by 25
Annaházi, A., Dabek, M., Gecse, K. B., Salvador–Cartier, C., Polizzi, A., Rosztoczy, A. I., Róka, R., Theodorou, V., Wittmann, T., Bueno, L. P., et al. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01805.x · Cited by 24
Self-citationActivity of Protease-Activated Receptors in Primary Cultured Human Myenteric Neurons
Kugler, E. M., Mazzuoli‐Weber, G., Demir, İ. E., Ceyhan, G. O., Zeller, F., & Schemann, M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00133 · Cited by 24
Application of metabolomics to the study of irritable bowel syndrome
Bennet, S., Keshteli, A. H., Berčík, P., Madsen, K. L., Reed, D. E., & Vanner, S. J. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13884 · Cited by 26
Trypsin-protease activated receptor-2 signaling contributes to pancreatic cancer pain
Zhu, J., Miao, X., Tao, K., Zhu, H., Liu, Z.-Y., Yu, D.-W., Chen, Q.-B., Qiu, H.-B., & Lu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.18696 · Cited by 23
Luminal contents from the gut of colicky infants induce visceral hypersensitivity in mice
Eutamène, H., García‐Ródenas, C. L., Yvon, S., d'Aldebert, E., Foata, F., Berger, B. W., Sauser, J., Théodorou, V., Bergonzelli, G. E., & Mas, E. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12994 · Cited by 22
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain
Brouillette, R. L., Besserer‐Offroy, É., Mona, C. E., Chartier, M., Lavenus, S. B., Sousbie, M., Belleville, K., Longpré, J., Marsault, É., Grandbois, M., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104750 · Cited by 19
Functional Gastrointestinal Disorders.
Duffy, M., Boggiano, V. L., Ganesh, R., & Mueller, M. (2023) · Primary Care · doi:10.1016/j.pop.2023.03.006 · Cited by 13
Shah, M. K., Ding, Y., Wan, J., Janyaro, H., Tahir, A. H., Vodyanoy, V. J., & Ding, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67702-2 · Cited by 18
Hanning, N., bruyn, M. D., Ceuleers, H., Boogaerts, T., Berg, M., Smet, A., Schepper, H. U. D., Joossens, J., van Nuijs, A. L. N., Man, J. G. D., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060811 · Cited by 18
Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S. C., Enck, P., Frieling, T., Haag, S., Holtmann, G., Karaus, M., Keller, J., et al. (2011) · Cited by 17
The proteolytic activity in inflammatory bowel disease: insight from gut microbiota
Hou, J., Ding, L., Yang, T., Yang, Y.-F., Jin, Y., Zhang, X., Ma, A.-H., & Qin, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106560 · Cited by 20
Quan, R., Decraecker, L., Appeltans, I., Cuende‐Estévez, M., Remoortel, S. V., Aguilera‐Lizarraga, J., Wang, Z., Hicks, G. A., Wykosky, J., McLean, P. G., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003042 · Cited by 16
Szymaszkiewicz, A., Storr, M., Fichna, J., & Zielińska, M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13526 · Cited by 16
Tahir, A. H., Li, J., & Tang, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.696843 · Cited by 16
McDougall, J. J., & Muley, M. M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_12 · Cited by 16
The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome
Hou, J., Wang, X., Li, Y., Su, S., Wang, Y., & Wang, B. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104995 · Cited by 18
Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS
Decraecker, L., Boeckxstaens, G. E., & Denadai‐Souza, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.880422 · Cited by 15
Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats
Shah, M. K., Wan, J., Janyaro, H., Tahir, A. H., Cui, L., & Ding, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00214 · Cited by 15
Margiotta, F., Lucarini, E., Toti, A., Curti, L., Masi, A., Mello, T., Gall, G. L., Mattei, G., Magi, A., Vauzour, D., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2547029 · Cited by 14
Hoffman, S., Cohen, N. A., Carroll, I. M., Tulchinsky, H., Borovok, I., Dotan, I., & Maharshak, N. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz086 · Cited by 14
Diet–microbial cross–talk underlying increased visceral perception
Palma, G. D., Reed, D. E., & Berčík, P. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2166780 · Cited by 13
bruyn, M. D., Ceuleers, H., Hanning, N., Berg, M., Man, J. G. D., Hulpiau, P., Hermans, C., Stenman, U., Koistinen, H. K., Lambeir, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910711 · Cited by 13
Cibert‐Goton, V., Lam, C., Lingaya, M. R., Falcone, Y., Wood, J. N., Bulmer, D. C., & Spiller, R. E. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000313 · Cited by 13
Tao, E., Long, G., Yang, T., Chen, B., Guo, R. C., Ye, D., Fang, M., & Jiang, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.803957 · Cited by 11
Soussou, S., Jablaoui, A., Mariaule, V., Kriaa, A., Boudaya, H., Wysocka, M., Amouri, A., Gargouri, A. F., Lesner, A., Maguin, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44454-3 · Cited by 16
Republished: Bacterial proteases in IBD and IBS
Steck, N., Mueller, K., Schemann, M., & Haller, D. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-300775rep · Cited by 11
Rodiño‐Janeiro, B. K., Pardo‐Camacho, C., Santos, J., & Martínez, C. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00186.2018 · Cited by 10
Ikehara, O., Hayashi, H., Waguri, T., Kaji, I., Karaki, S.-I., Kuwahara, A., & Suzuki, Y. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0198-7 · Cited by 9
X-ray structure of an inactive zymogen clostripain-like protease fromParabacteroides distasonis
González-Páez, G. E., Roncase, E. J., & Wolan, D. W. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319000809 · Cited by 9
Ceuleers, H., Hanning, N., bruyn, M. D., Man, J. G. D., Schepper, H. U. D., Li, Q., Liu, L., Abrams, S., Smet, A., Joossens, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.765744 · Cited by 8
Metabolic biomarkers in irritable bowel syndrome diagnosis
Vakili, O., Sedeh, P. A., & Pourfarzam, M. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119753 · Cited by 8
Dysbiosis of the Intestinal Microbiota in IBS
Lyra, A., & Lahtine, S. (2012) · InTech eBooks · doi:10.5772/25759 · Cited by 9
Recording from human gut tissue: a major step towards more efficient drug development?
Schemann, M. (2011) · Gut · doi:10.1136/gut.2010.225664 · Cited by 6
Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment
Defaye, M., Nasser, Y., & Altier, C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01139-8 · Cited by 7
Guo, P., Zhang, Q., Nan, S., Wang, H., Ma, N., Kiani, F. A., Ding, M., & Chen, J. (2023) · Brain Sciences · doi:10.3390/brainsci13060922 · Cited by 4
Animal Models and Experimental Research in Medicine
Karapehlivan, M., Gelen, V., & Kükürt, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100993 · Cited by 4
Targeting of Transient Receptor Potential Channels in Digestive Disease
Poole, D. P., Lieu, T., Veldhuis, N. A., Rajasekhar, P., & Bunnett, N. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420024-1.00021-7 · Cited by 3
Microbial Neuro-Immune Interactions and the Pathophysiology of IBD
Aguilera, M., & Melgar, S. (2016) · InTech eBooks · doi:10.5772/64832 · Cited by 4
Faure, C. C., & Righini‐Grunder, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-43268-7_4 · Cited by 4
Bulmer, D. C., & Roza, C. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190860509.013.12 · Cited by 3
Emerging therapeutic approaches for treating abdominal pain
Jiménez-Vargas, N. N., Parkar, N., Takami, K., Wood, H. M., Lomax, A. E., Reed, D. E., & Vanner, S. J. (2025) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwaf016 · Cited by 2
Current Status of Translational Research on Irritable Bowel Syndrome
Kwon, Y. H., & Kim, H. J. (2016) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2016.68.3.138 · Cited by 2
Quigley, E. M. M. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.245 · Cited by 3
Jiménez-Vargas, N. N., Sokrat, B., Gilmor, D. A., Fialho, M. F. P., Guzmán-Rodríguez, M., Nakhle, R., Shi, Y., Davidson, S., Schmidt, B. L., Reed, D. E., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337991 · Cited by 1
Miranda, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-15229-0_4 · Cited by 1
The Biomechanics of Distal Colon and Rectum and Its Relevance to Visceral Pain
Feng, B., & Pierce, D. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25702-5_7 · Cited by 1
Syndrome de l’intestin irritable : une maladie inflammatoire ?
Piche, T., & Dainese, R. (2010) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2010.02.004 · Cited by 1
Clinical Connections Between the Microbiota and Breast Cancer (Onset, Progression and Management)
Filippone, A., & Magno, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00099-1 · Cited by 1
The origins of pain in diverticular disease: peripheral or central?
Smith, J. K. (2013) · Nottingham ePrints (University of Nottingham) · Cited by 1
Giardia Cathepsins and Their Role in Intestinal Disease
Bhargava, A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26304
Towards accessing the proteolytic potential of the gut microbiota
Morris, L. S. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Metadata
- Authors
- Annaházi, A., Gecse, K., Dabek, M., Ait-Belgnaoui, A., Rosztóczy, A., Róka, R., Molnár, T., Theodorou, V., Wittmann, T., Bueno, L., & Eutamene, H.
- Affiliations
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- University of Szeged (HU)
- Venue
- Pain
- Published
- 2009-07
- Volume
- 144
- Issue
- 1
- Pages
- 209-217
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1973233423
- Cited by
- 112
- References
- 37
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 7
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Institut National de la Recherche Agronomique
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diarrhea-predominant irritable bowel syndrome, ulcerative colitis, visceral sensitivity, colonic hypersensitivity, proteinase-activated receptor 4, protease-activated receptor 2, cathepsin G, serine protease, colorectal distension, fecal supernatants, pepducins, inflammatory bowel disease
- MeSH terms
- Adult, Analysis of Variance, Animals, Colitis, Ulcerative, Enzyme Inhibitors, Feces, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Perception, Sensory Thresholds, Serine Endopeptidases, Viscera, Irritable Bowel Syndrome, Receptors, Proteinase-Activated, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review